Flotte’s Outline of

Neuroscience

Edward R. Flotte, 2008

 

 

Home

 

 

NEUROLOGY

 

 

 

 

Degenerative Diseases

Alzheimer’s Disease

·         German neurologist Alois Alzheimer described the case of his patient Auguste D, a woman who developed dementia in her 50s and died in 1906.

·         An estimated 25 million people worldwide have Alzheimer's disease.

·         Diagnosis: Clinical. No comfirmatory tests exist. 

·         Symptoms: Memory loss, aphasia, apraxia.

·         Pathophysiology: Decreased acetylcholine (Nucleus Basalis of Meynert), norepinephrine, dopamine, & serotonin. 

·         Apolipoprotein E4/E4 increases the number of plaques of plaques, early onset.

·         Associated with Chromosome 21 (as in Down’s syndrome) (also 14,19).

Pathology

·         Cortical & hippocampal atrophy

·         Neurofibrillary tangles: t protein. Neuritic plaques: bamyloid protein. Both: cytoplasmic, silver stained, paired helical filaments.

·         Granulovacular degeneration: dark cytoplasmic granules w/clear halo in neurons.

·         No gliosis.

Treatment

·         Acetylcholinesterase inhibitors: donepezil, tacrine. Slow progression.

·         Vitamin E

·         Selegiline: MAOI. Delays nursing home placement, but not cognitive decline).

 

Huntington’s Disease

·         Diagnosis: Chorea, demetia, family Hx.

·         Personality change occurs early, increased blinking, abnormal eye movement.

·         Caudate/putamen atrophy > boxcar ventricles.

·         Genetics: AD, CAG repeat in protein huntingtin, chr 4.

·         ­ dopamine, NE, somatostatin (vs Alzheimers); ¯ GABA, Ach. L-dopa worsens.

·         Westphal variant: <20yo, more aggressive, seizures, parkinsonism.

 

Subcortical dementias

·         No aphasia, apraxia, or amnesia (memory OK). Seen in Parkinsons & Huntingtons

 

Pick’s disease

·         Frontal/ temporal atrophy

·         Path: Balloon (“Picks”) cells (neurons, tau+). Neuron loss in cerebral cortex, gliosis, cortical spongiosis.

<